NCT01750086View on ClinicalTrials.gov

Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

August 31, 2014

Conditions
Postmenopausal Osteoporosis
Interventions
DRUG

Teriparatide 40-mcg subcutaneous injection

DRUG

Denosumab Injection

One-time Denosumab injection

DRUG

Alendronate Oral Tablet

weekly alendronate for 8 weeks

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT01750086 - Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption | Biotech Hunter | Biotech Hunter